Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingJul 8, 2026Dextroamphetamine SaccharateLabeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.Lannett Company Inc. · D-0660-2026Class IIOngoingJul 8, 2026Lidocaine HCl Injection USPLack of Assurance of SterilityAsclemed USA Inc. · D-0659-2026Class IIOngoingJul 8, 2026AccucaineLack of Assurance of SterilityAsclemed USA Inc. · D-0658-2026Class IIOngoingJul 8, 2026Synjardy XR TabletsCGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different...Boehringer Ingelheim Pharmaceuticals, Inc. · D-0657-2026Class IIOngoingJul 8, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0656-2026Class IIOngoingJul 8, 2026prednisoLONE Acetate Ophthalmic SuspensionPresence of Foreign SubstanceLupin Pharmaceuticals Inc. · D-0655-2026Class IIIOngoingJul 8, 2026Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries Inc · D-0654-2026Class IIOngoingJul 8, 2026IMULDOSALack of assurance of Sterility:Accord Biopharma Inc · D-0653-2026Class IIOngoingJul 8, 2026BD ChloraPrep CLearLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0652-2026Class IIOngoingJul 8, 2026BD ChloraPrep CLearLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0651-2026Class IIOngoingJul 8, 2026BD ChloraPrep Scrub TealLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0650-2026Class IIOngoingJul 8, 2026BD ChloraPrep Scrub TealLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0649-2026Class IIOngoingJul 8, 2026BD ChloraPrep Hi-Lite OrangeLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0648-2026Class IIOngoingJul 8, 2026BD ChloraPrep Hi-Lite OrangeLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0647-2026Class IIOngoingJul 8, 2026ChloraPrep FREPPLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0646-2026Class IIOngoingJul 8, 2026BD ChloraPrep ClearLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0645-2026Class IIOngoingJul 8, 2026BD PurPrepLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0644-2026Class IIOngoingJul 8, 2026BD ChloraPrep Hi-Lite OrangeLack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers...CareFusion 213, LLC · D-0643-2026Class IIOngoingJul 1, 2026Perampanel CIII TabletsLabeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.Sun Pharmaceutical Industries Inc · D-0628-2026Class IIOngoingJul 1, 2026Povi-Onesub potencyElevate Oral Care · D-0627-2026Class IIOngoingJul 1, 2026Lacosamide TabletsPresence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.Annora Pharma Private Limited · D-0626-2026Class IOngoingJul 1, 2026BD ChloraPrep FREPP ClearNon-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.CareFusion 213, LLC · D-0625-2026Class IOngoingJul 1, 2026BD ChloraPrep ClearNon-Sterility: Due to presence of Aspergillus penicillioides.CareFusion 213, LLC · D-0624-2026Class IIOngoingJul 1, 2026BD ChloraPrep FREPP ClearLack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.CareFusion 213, LLC · D-0623-2026Class IIOngoingJul 1, 2026BD ChloraPrep ClearLack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.CareFusion 213, LLC · D-0622-2026Class IIOngoingJul 1, 2026PReye Vitamin See Antioxidant Preservative Free Eye DropsLack of Assurance of SterilityPReye LLC · D-0621-2026Class IIIOngoingJul 1, 2026hydrOXYzine Hydrochloride Oral SolutionPresence of foreign substanceANI Pharmaceuticals, Inc. · D-0619-2026Class IIOngoingJul 1, 2026Total Parental Nutrition - Pediatric PN Patient-Specific TPN BagIncorrect product formulation: bag did not contain copper and famotidine per label.Central Admixture Pharmacy Services, Inc. · D-0618-2026Class IIOngoingJul 1, 2026DULOXETINE D/RCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitDirect Rx · D-0617-2026Class IIOngoingJul 1, 2026SensiparCGMP DeviationsAmgen, Inc. · D-0616-2026Class IIOngoingJul 1, 2026CorlanorPresence of Foreign Substance.Amgen, Inc. · D-0615-2026Class IIOngoingJul 1, 2026SensiparCGMP DeviationsAmgen, Inc. · D-0614-2026Class IIOngoingJul 1, 2026SensiparCGMP DeviationsAmgen, Inc. · D-0613-2026Class IIOngoingJul 1, 2026CorlanorPresence of Foreign Substance.Amgen, Inc. · D-0612-2026Class IIOngoingJul 1, 2026Fenofibrate CapsulesCGMP DeviationsAjanta Pharma USA Inc · D-0611-2026Class IIOngoingJul 1, 2026Carton Label: MAJORSubpotent DrugThe Harvard Drug Group LLC · D-0609-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0642-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0641-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0640-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0639-2026